Sarah London Appointed to Plaintiffs’ Executive Committee in Gilead HIV Drug Kidney & Bone Injuries Litigation

Sarah London Appointed to Plaintiffs' Executive Committee in Gilead HIV Drug Kidney & Bone Injuries Litigation

On February 5, 2020, Judge Andrew Y.S. Cheng of the Superior Court for the County of San Francisco issued an order appointing Lieff Cabraser partner Sarah R. London  to the Plaintiffs’ Executive Committee in the Gilead HIV Drug Kidney & Bone Injuries Litigation. Sarah will lead the litigation on behalf of patients across California who allege they suffered kidney and bone injuries from HIV drugs made and distributed by pharmaceutical giant Gilead Sciences, Inc. [Read more…]

Plaintiffs Seek Relocation for Gilead Sciences Inferior HIV Drugs Trial

Plaintiffs Seek Relocation for Gilead Sciences Inferior HIV Drugs Trial

In lawsuits against pharma giant Gilead Sciences, plaintiffs across California allege they suffered ill effects from HIV drugs made and distributed by Gilead that were more harmful derivatives than other drugs the company had created but not sold until its stock of the inferior drugs was exhausted. As reported by the Daily Journal (subscription), attorneys for some of those plaintiffs are asking the judge to switch the case to a venue and location that would be more reachable and meaningful than the current Santa Clara County location. In an earlier tentative ruling, California Superior Court Judge Kenneth R. Freeman proposed that the 19 consolidated personal injury lawsuits be tried in Santa Clara County. Alternative venue suggestions include Alameda, San Francisco and Los Angeles counties. [Read more…]